Nurse Manager - Moorabbin Chemotherapy Day unit (60180) Monash Health
Closing date: 23 May 2023
Working in Healthcare has never been more important or meaningful
Our Journey:Cancer Services is across several Monash Health sites, Moorabbin, Clayton, Casey. Moorabbin Chemotherapy Day Unit treats both Oncology and Haematology patients, supported by Peter MacCallum radiology services.
Monash Health Moorabbin Chemotherapy Day Unit treated over 750 new patients in the 21-22 financial year resulting in over 9,000 treatments.
A Day in the Life:The Nurse Manager of the Moorabbin Chemotherapy Day unit is a key leadership position within Cancer Services. The successful applicant will be working closely with the Cancer ward Nurse Managers at Moorabbin and Clayton, the Nurse Manager of the Medical Infusion Unit at Clayton as well as Peter MacCallum radiotherapy who have a satellite site at Moorabbin.
The Moorabbin Chemotherapy Day Unit is currently open Monday to Friday 0700-2130.
This is a Part Time fixed term position for 12 months.
About You:You have been developing your management and leadership skills or you are an accomplished Associate Nurse Manager; either way, you are ready to take this next step in your Career.
You lead by example, thrive working in a dynamic, fast paced environment and are truly passionate about delivering a high standard of evidence-based nursing care to all patients. You are an advocate of Monash Health’s Strategic Guiding Principles.
You also demonstrate
What you need:
For a confidential discussion and to explore the opportunity further, please call Kim Rogers on 0409 791 130
How to Apply
Applications are only accepted that are submitted via the Monash Health online Mercury System (e-recruit).
To view the position description click here
A role is available on the Central Coast:
Blood 2022 Sydney
Travel Grants for Haematology Nurses
Closing Date: Tuesday 26 July 2022 – Midnight
WHO CAN APPLY?
This grant is open to HSANZ Nurse Associate members for attendance at Blood 2022. This conference will be held in Sydney from the 11th - 14th September 2022.
WHAT DOES THE TRAVEL GRANT INCLUDE?
The recipients of the grants will be awarded $500 - $1000 depending on state of residence.
WHO IS PROVIDING THIS GRANT?
HSANZ are supporting these grants to be awarded via the HSANZ Nurses' Group.
HOW MANY AWARDS ARE AVAILABLE?
There are 9 different haematology associate nurse member grants available.
GUIDELINES / CRITERIA FOR APPLICANTS
Applicants must be current financial associate nurse members of HSANZ.
Applicants receiving the travel grant will be required to provide a short written report after the conference for the HSANZ Nurses' Group newsletter published post conference.
Applicants will be required to present their abstract (if applicable) at a HSANZ Nurses' Group state education meeting at the end of 2022.
Applicants receiving support will acknowledge their sponsorship through HSANZ Nurses Group in any presentations, handouts or publications.
For more information or any questions, please do not hesitate to contact Nicole Gavin HSANZ Nurses’ Group President Email
Click here for the application form
The Annual Lymphoma Australia Nursing Conference is fast approaching and you are running out of time to register.
Details: 28th and 29th July Hybrid Event in the Hunter Valley
Further details are available on our website including information on how to register to attend, booking the shuttle service to the conference and also accommodation. Click here
We have a special code for HSANZ members, that will give you FREE registration, if you register before the 15th July. The code is LAFREE.
Our finalised agenda can be found below.
Click to find out more information
Current and former Nurses presidents, Nicole Gavin and Elise Button recently published an article on values and preferences of haematology patients near the end of life. Much of the data came from the HSANZ membership (via the mailing list and at conference - see methods section of publication).
Click here for the publication
Are you an internationally educated nurse working in cancer or palliative care setting in Australia?
Have you obtained your initial nursing qualification overseas before migrating to Australia?
We are seeking for volunteers to participate in our study.
What is this study about?
This research aims to understand the experiences of internationally educated nurses (IEN) in the context of cancer and end-of-life care. This study explores and analyses how cultural beliefs and practices of IENs inform their delivery of nursing care. Considering the cultural diversity of Australia and its nursing workforce, understanding this phenomenon deserves attention to advance culturally sensitive care and enhance IENs' workplace experience.
You will contribute valuable information to advance knowledge and understanding of your experience and may inform future strategies to enhance your work experience.
Who can participate?
What do I need to do?
If you are interested in participating or would like more information, please contact Jay Balante at firstname.lastname@example.org or through mobile at 0410 808 159. If you know someone who might be interested in participating, please share the study information with them.
For more information click here
This study has been approved by the Sydney Local Health District Human Research Ethics Committee – Concord Repatriation General Hospital (Protocol Number: 2020/ETH02502).
HSANZ has endorsed these Guidelines and provide them for your information. Nicole Gavin, HSANZ Associate Nurse Member was one of the authors.
CNSA would like to extend a heartfelt thanks to our Vascular Access Device & Infusion Therapy Specialist Practice Network (VAD&IT SPN), eviQ and all who have worked tirelessly to develop the revised CNSA Vascular Access Devices: Evidence Based Clinical Practice Guidelines. In a CNSA first, these guidelines are hosted directly on the CNSA website and detail the latest evidence and recommendations for patients with cancer with peripheral intravenous cannulas and central venous access devices.
The guidelines provide standardised, evidence-based clinical practice guidelines and recommendations for the safe, effective, and efficient management of vascular access devices for the patient with cancer. This knowledge base, with clinical expertise, the preferences of the individual patient, product knowledge and application, and local context of the individual healthcare environment can be integrated into comprehensive approach to vascular access management for the individual cancer patient.
They have been received enthusiastically within Australia, with endorsement coming from the Australia Vascular Access Society (AVAS), the Alliance for Vascular Access Teaching and Research (AVATAR), the Clinical Oncology Society of Australia (COSA) Intravenous Nursing New Zealand (IVNNZ) and Haematology Society of Australia and New Zealand (HSANZ).
These guidelines cover Patency, Occlusion Prevention and Management and include:
You can now access these online at www.cnsa.org.au/VADguidelines. or
eviQ – content author – Nursing/Haematology & BMT – Full-time permanent
The Cancer Institute NSW St Leonards
For full details click here
The HSANZ Nurses Group Myeloma Specialist Practice Network is a very active group, with Tracy King at the helm. She not only applied for and received funding from a pharma company, however, also received an Innovation Award for developing MyeTxScheduler, a tool for clinicians to create treatment schedules to help patients to adhere to treatment protocols. The tool is pre-populated with standard myeloma treatment scheduled based on eviQ protocols, with flexibility to adapt to individual patient needs.
It is being rolled out in stages across Australia and New Zealand.
More details here
President: Nicole Gavin (QLD)
Nicole Gavin is Senior Research Fellow at Queensland University of Technology and Nurse Research at the Royal Brisbane and Women’s Hospital with adjunct affiliations at the University of Queensland and Griffith University. She is an experienced haematology and bone marrow transplant nurse. Nicole’s PhD investigated the effect of parenteral nutrition on microbial growth and its influence on catheter-related infection in patients with a central venous access device. Her postdoctoral research is broadly focused in preventing and managing infections in patients diagnosed with cancer. Nicole has been an associate nurse member of HSANZ since 2010 and has been the Queensland Representative and Vice President.
Vice President – and WA rep: Andrew Steele
Andy started working in Oncology upon qualification in 1991. His first role in Haematology was 3 years later at Derriford Hospital Plymouth and he became Charge nurse there in 1998, attending the EBMT conference the same year.
In 2000 Andy moved to Kalgoorlie WA, working in Restorative and Palliative care as a manager and stayed there for 2 years before moving to Perth to work on the Haematology ward. He stayed there for 14 years night and day and then moved to the Haematology Day Ward as Clinical Nurse Specialist and then Manager in 2014. He has been a Nurses Representative for WA since 2015. He has an interest in Change theory presenting several times at the Blood conference and organised and chaired the nurses stream of Blood 2019 in Perth.
Treasurer – Elise Button
Elise Button is a Research Fellow in the Centre for Healthcare Transformation, Queensland University of Technology and Nurse Researcher in Cancer Care Services at the Royal Brisbane and Women’s Hospital. She is an experienced haematology and bone marrow transplant nurse and an early career researcher. Elise’s research interests are focused on integration of palliative care, quality measures of end-of-life care and value-based health care.
Qld State Representative Jodie Marsh
Jodie is a Nurse Practitioner Townsville University Hospital. She has 23 years’ experience in Cancer Nursing with the majority involved in Haematology, Blood and Marrow Transplant and apheresis. She is an active member of both Haematology and BMT reference group committees with EVIQ and State Wide Cancer Clinical Network Specialist Education Committee. Clinical areas of interest are Clinical Morphology, Acute Leukemias, Apheresis and Blood and Marrow Transplant. Qld Pathology credentialled in procedural Bone Marrow Biopsy.
Myeloma Specialist Practice Network - Tracy King RN MN
Tracy King is a past President of the Nurses Group and currently, Myeloma Clinical Nurse Consultant at Royal Prince Alfred Hospital; Clinical Research Fellow, Lecturer and PhD candidate at the Cancer Nursing Research Unit, Sydney University. With over 28 years’ experience in the field of Haematology / BMT, Tracy developed a specialist interest in myeloma 20yrs ago working with the International Myeloma Foundation (IMF), now Myeloma UK. Since coming to Australia Tracy has been an active member of a range of national and international professional working groups including those of the Cancer Institute NSW; Myeloma and Related Disease Registry (MRDR), Chair of the HSANZ Myeloma Specialist Practice Network (M-SPN) and Past President and co-founder of the HSANZ Nurses Group. Most recently Tracy has been invited as a member of the IMF Nurse Leadership Board (NLB) and leads the nurse’s program development and delivery during the International Myeloma Workshop (IMW). Tracy completed a master’s in nursing leadership and is currently a PhD candidate at Sydney University. She was awarded the Outstanding Research Achievement Nursing & Midwifery Award 2019 by Sydney Local Health Network (SLHD) for her leadership and research in better understanding the experiences of those affected by myeloma taking high dose steroids and the role of patient reported outcome measures (PROM).
© 2023 Haematology Society of Australia & New Zealand All Rights Reserved.